Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
Lactobacillus rhamnosus GR-1 |
?
Supplementation with fruit and okara soybean by-products and amaranth flour increases the folate production by starter and probiotic cultures. International journal of food microbiology (Int J Food Microbiol ) Vol: 236 Issue Pages: 26-32 Pub: 2016 Nov 7 Epub: 2016 Jul 11 Authors Albuquerque MA , Bedani R , Vieira AD , LeBlanc JG , Saad SM , Publication |
Lactobacillus rhamnosus GR-1 |
?
Effect of probiotics on multi-resistant organism colonisation in persons with spinal cord injury: secondary outcome of ProSCIUTTU, a randomised placebo-controlled trial. Spinal cord (Spinal Cord ) Vol: 58 Issue 7 Pages: 755-767 Pub: 2020 Jul Epub: 2020 Jan 17 Authors Toh SL , Lee BB , Simpson JM , Rice SA , Kotsiou G , Marial O , Ryan S , Publication |
Lactobacillus rhamnosus GR-1 |
?
Probiotic Lactobacillus rhamnosus GR-1 is a unique prophylactic agent that suppresses infection-induced myometrial cell responses. Scientific reports (Sci Rep ) Vol: 9 Issue 1 Pages: 4698 Pub: 2019 Mar 18 Epub: 2019 Mar 18 Authors Kim B , Shynlova O , Lye S , Html Article Publication |
Lactobacillus rhamnosus GR-1 |
?
Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial. Spinal cord (Spinal Cord ) Vol: 57 Issue 7 Pages: 550-561 Pub: 2019 Jul Epub: 2019 Feb 27 Authors Toh SL , Lee BB , Ryan S , Simpson JM , Clezy K , Bossa L , Rice SA , Marial O , Weber GH , Kaur J , Boswell-Ruys CL , Goodall S , Middleton JW , Tuderhope M , Kotsiou G , Html Article Publication |
Lactobacillus rhamnosus GR-1 |
?
Lactobacillus rhamnosus Probiotic Food as a Tool for Empowerment Across the Value Chain in Africa. Frontiers in microbiology (Front Microbiol ) Vol: 9 Issue Pages: 1501 Pub: 2018 Epub: 2018 Jul 10 Authors Westerik N , Kort R , Sybesma W , Reid G , Html Article Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.